Found 13 matching trials
Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to MTX Therapy PHASE3 This is a phase III, double-blind, randomized, multicenter, and parallel gr...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis PHASE2 Ofatumumab is a novel Immunoglobulin 1ĸ ( IgG1ĸ) lytic monoclonal antibody ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy PHASE3 This is a phase III, double-blind, randomized, multicenter, and parallel gr...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Efficacy and Safety of Ofatumumab Compared to Placebo in Patients With Relapsing Multiple Sclerosis Followed by Extended Treatment With Open-label Ofatumumab PHASE2 The study provided efficacy, safety, and pharmacokinetics (PK) data for pat...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403 PHASE2 A 3-year open-label trial for patients who previously participated in Trial...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris PHASE3 Pemphigus vulgaris (PV) is a rare, chronic, debilitating, and potentially l...
Show More Location
Novartis Investigational Site
Learn More & Join Trial
Ofatumumab Dose-finding in Relapsing Remitting Multiple Sclerosis (RRMS) Patients PHASE2 The trial consists of a dose escalation, to establish the safety of ofatumu...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis. PHASE3 To compare the efficacy and safety of ofatumumab administered subcutaneousl...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Ofatumumab in Children With Drug Resistant Idiopathic Nephrotic Syndrome PHASE2 Double-blind, two-parallel-arm, placebo-controlled randomized clinical tria...
Show More Location
IRCCS Istituto Giannina Gaslini
Learn More & Join Trial
HuMax-CD20 in Active Rheumatoid Arthritis, Phase I/II PHASE2 The purpose of this trial is primarily to investigate the safety profile of...
Show More Location
Multiple Locations
Learn More & Join Trial